Bourgeon Capital Management LLC Has $11.58 Million Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Bourgeon Capital Management LLC decreased its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 1.1% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 22,106 shares of the healthcare conglomerate’s stock after selling 255 shares during the quarter. UnitedHealth Group makes up 2.5% of Bourgeon Capital Management LLC’s investment portfolio, making the stock its 12th biggest holding. Bourgeon Capital Management LLC’s holdings in UnitedHealth Group were worth $11,578,000 as of its most recent SEC filing.

Several other large investors have also bought and sold shares of UNH. NewSquare Capital LLC acquired a new position in shares of UnitedHealth Group in the fourth quarter worth approximately $25,000. Marshall & Sterling Wealth Advisors Inc. acquired a new position in shares of UnitedHealth Group in the 4th quarter worth approximately $26,000. Hurley Capital LLC acquired a new stake in shares of UnitedHealth Group during the fourth quarter worth $28,000. Aster Capital Management DIFC Ltd acquired a new position in UnitedHealth Group in the fourth quarter valued at $30,000. Finally, Promus Capital LLC acquired a new stake in UnitedHealth Group during the 4th quarter worth about $32,000. 87.86% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

UNH has been the topic of several research analyst reports. JPMorgan Chase & Co. cut their target price on UnitedHealth Group from $525.00 to $405.00 and set an “overweight” rating on the stock in a research report on Thursday, May 15th. KeyCorp reduced their price objective on shares of UnitedHealth Group from $450.00 to $400.00 and set an “overweight” rating for the company in a research report on Monday. Argus downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Monday, April 21st. Barclays decreased their price target on shares of UnitedHealth Group to $350.00 and set an “overweight” rating for the company in a research note on Monday. Finally, TD Securities restated a “hold” rating and issued a $308.00 target price (down from $520.00) on shares of UnitedHealth Group in a research note on Monday, May 19th. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating and seventeen have assigned a buy rating to the stock. According to data from MarketBeat.com, UnitedHealth Group currently has an average rating of “Moderate Buy” and an average target price of $439.17.

UnitedHealth Group Price Performance

UNH opened at $304.27 on Tuesday. The firm’s fifty day moving average price is $426.60 and its two-hundred day moving average price is $490.74. The company has a market capitalization of $276.01 billion, a price-to-earnings ratio of 19.63, a P/E/G ratio of 1.37 and a beta of 0.56. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a 1 year low of $248.88 and a 1 year high of $630.73.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm had revenue of $109.58 billion during the quarter, compared to analysts’ expectations of $111.56 billion. During the same quarter last year, the business posted $6.91 EPS. As a group, analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, CEO Stephen J. Hemsley bought 86,700 shares of the firm’s stock in a transaction on Friday, May 16th. The stock was acquired at an average cost of $288.57 per share, with a total value of $25,019,019.00. Following the completion of the transaction, the chief executive officer now directly owns 679,493 shares of the company’s stock, valued at $196,081,295.01. This represents a 14.63% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Kristen Gil purchased 3,700 shares of the business’s stock in a transaction dated Thursday, May 15th. The shares were purchased at an average price of $271.17 per share, with a total value of $1,003,329.00. Following the purchase, the director now directly owns 3,818 shares in the company, valued at $1,035,327.06. This trade represents a 3,135.59% increase in their position. The disclosure for this purchase can be found here. Over the last quarter, insiders have acquired 109,408 shares of company stock valued at $31,607,768. Insiders own 0.33% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.